Product NewsDrug discovery > Pre-Clinical Development
FcRn model platform
6 Feb 2024
In this video, The Jackson Laboratory introduces the FcRn platform, which mimics specific aspects of human IgG physiology. This platform serves as an ideal model for assessing the pharmacokinetics (PK) of therapeutic antibody candidates during the preclinical stages of drug development.
About the company
The Jackson Laboratory
The Jackson Laboratory is a global leader in preclinical studies and has been driving therapeutic development breakthroughs for over 90 years. With the most innovative preclinical platforms including humanized mice, and services such as dose ranging, toxicity, and efficacy studies, JAX empowers drug developers and researchers worldwide.
